Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.22.2
Related Party Transactions (Details)
 3 Months Ended 6 Months Ended
Apr. 08, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Director
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Pre-Merger Financing and Waiver Agreements [Abstract]            
Number of directors signed waiver agreements | Director       6    
Director [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Consulting fee payable in cash | $ $ 10,000          
Number of stock option granted (in shares) 50,000          
Vesting period       36 months    
Consulting expenses | $   $ 30,000 $ 0 $ 30,000 $ 0  
Consulting expenses unpaid | $   $ 10,000   $ 10,000   $ 0
Director [Member] | Vesting on March 31, 2023 [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Vesting percentage 25.00%          
Pre-Merger Financing [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Number of directors | Director       5    
Amount invested in pre-merger financing | $       $ 300,000    
Number of converted initial shares received by directors (in shares)   17,729   17,729    
Number of converted additional shares (in shares)   53,189   53,189    
Pre-Merger Financing [Member] | Rexahn [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Number of directors | Director       1    
Pre-Merger Financing [Member] | Series A Warrants [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Number of converted additional shares (in shares)   80,366   80,366    
Pre-Merger Financing [Member] | Series B Warrants [Member]            
Pre-Merger Financing and Waiver Agreements [Abstract]            
Number of converted additional shares (in shares)   9,444   9,444